Panel Discussion: Accelerating iPSC Therapy Development by Streamlining Processes & Mitigating Delays
Time: 4:00 pm
day: Conference Day Two
Details:
- Minimizing the need for retesting when transitioning between research-grade and GMP-compliant materials and processes, reducing development timelines and associated costs
- Streamlining iPSC production workflows through automation, integration of advanced technologies, and process optimization to expedite development timelines and reduce overall costs
